[HTML][HTML] The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process …
Q Wang, S Liu, Z Nie, Z Zhu, Y Fu, J Zhang… - Journal of Global …, 2023 - ncbi.nlm.nih.gov
Background Generic drugs have been seen as a potentially powerful way to alleviate the
financial burden on patients and health care systems. Two strategies for achieving rational …
financial burden on patients and health care systems. Two strategies for achieving rational …
[HTML][HTML] New pricing models for generic medicines to ensure long-term sustainable competition in Europe
C Francois, G Gawlik, J Mestre-Ferrandiz… - Frontiers in …, 2023 - frontiersin.org
Background: Price erosion of generic medicines over time as a result of existing pricing
policies in combination with increasing operational costs of these products due to high …
policies in combination with increasing operational costs of these products due to high …
[HTML][HTML] Modeling tiered pricing frameworks: A simulation approach
Objective Drug plans take different approaches to determining reimbursement prices for
generic drugs. One common approach is to set the maximum reimbursement price as a …
generic drugs. One common approach is to set the maximum reimbursement price as a …
The impact of price-cap regulations on market entry by generic pharmaceutical firms
W Zhang, H Sun, D Guh, AH Anis - Expert Review of …, 2017 - Taylor & Francis
Background: In 1998, the province of Ontario, Canada implemented price-cap '70/90ʹ
regulations: the first generic must be priced at≤ 70% of the associated brand-name price …
regulations: the first generic must be priced at≤ 70% of the associated brand-name price …
[HTML][HTML] Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?
KB Son - Frontiers in Public Health, 2022 - frontiersin.org
Background Price competition has the potential to reduce health expenditures without
hindering pharmaceutical innovation. However, empirical evidence on price competition …
hindering pharmaceutical innovation. However, empirical evidence on price competition …
Medicine Prices in the United States and Canada
A Hollis, P Grootendorst - Medicine Price Surveys, Analyses and …, 2019 - Elsevier
Abstract The United States and Canada are unique in their reliance on a mixed public–
private system of drug insurance. Prices paid are among the highest globally, with US prices …
private system of drug insurance. Prices paid are among the highest globally, with US prices …